Shenzhen Salubris Pharma Stock Drops 10% Amid Market Shift: What Investors Need to KnowShenzhen Salubris stock drops nearly 10% amid high volume—why investors fear overvaluation and what it means for the pharma sector.SALUBRIS Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated 04/04/2026, 11:39 2 minutes to read
